SGMO - Sangamo Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SGMO is currently covered by 11 analysts

Sangamo Therapeutics's activity chart (see below) currently has 37 price targets and 67 ratings on display. The stock rating distribution of SGMO is 5.56% SELL, 72.22% BUY and 22.22% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.49% with an average time for these price targets to be met of 222.08 days.

Highest price target for SGMO is $2, Lowest price target is $2.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 27-Jan-2025. First documented stock forecast 09-Jan-2014.

Currently out of the existing stock ratings of SGMO, 2 are a SELL (5.56%), 26 are a BUY (72.22%), 8 are a HOLD (22.22%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

1 years 8 months 1 days ago
(27-Jan-2025)

0/7 (0%)

$7.69 (332.90%)

Buy

$5

$3.96 (380.77%)

1 years 8 months 5 days ago
(23-Jan-2025)

0/2 (0%)

$3.81 (320.17%)

Hold

$2

$0.96 (92.31%)

$3

1 years 8 months 26 days ago
(02-Jan-2025)

2/5 (40%)

$0.87 (76.99%)

541

Buy

$3

$1.96 (188.46%)

$23

1 years 8 months 28 days ago
(31-Dec-2024)

1/5 (20%)

$1.98 (194.12%)

104

Buy

$9

$7.96 (765.38%)

1 years 10 months 14 days ago
(14-Nov-2024)

2/3 (66.67%)

$6.85 (318.60%)

371

Show more analysts

Please expand the browser size to see the chart

What is SGMO (Sangamo Therapeutics) average time for price targets to be met?

On average it took 222 days for the stock forecasts to be reached, with an average price target met ratio of 44.49%.

Which analyst most recently updated their price target on SGMO (Sangamo Therapeutics)?

Patrick Trucchio

Which analyst has the most public recommendations on SGMO (Sangamo Therapeutics)?

Patrick Trucchio has 9 price targets and 15 ratings on SGMO

Which analyst is the currently most bullish on SGMO (Sangamo Therapeutics)?

Charles Duncan with the highest potential upside of $17.96

Which analyst is the currently most reserved on SGMO (Sangamo Therapeutics)?

Yanan Zhu with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?